Profil bibliographique

Midori Morita

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

4Publications signalées

0Citations signalées

2Affiliations récentes

Les institutions déclarées

Kyoto Prefectural University Kyoto Prefectural University of Medicine

Les domaines associés

Breast Cancer Treatment StudiesBRCA gene mutations in cancerBone health and osteoporosis researchHER2/EGFR in Cancer ResearchGenomic variations and chromosomal abnormalities

Les publications récentes

Accès ouvert 2026 preprint OpenAlex

Real-World Landscape of Genomic Medicine in Breast Cancer Revealed by the C-CAT Database: Reappraisal of Drug Accessibility and Clinical Utility in 6,307 Patients

Midori Morita, Sae Kitano, Ryo Tsunashima, T. Yoshinami et autres

jp, pl (code pays fourni par la source)

0 citations Research Square

2026 article OpenAlex

Integration of gene expression profiling and mutation analysis via RNA sequencing: transitioning the 95-gene classifier to a next-generation platform in early-stage HR+/HER2- breast cancer

Chikage Kato, Yoshiaki Sota, Sae Kitano, A. Watanabe et autres

jp (code pays fourni par la source)

0 citations Breast Cancer

Accès ouvert 2026 preprint OpenAlex

Copy Number–Based Chromosomal Instability Ex-Score Predicts Breast Cancer Malignancy

Chise Matsui, Seiichi Imanishi, Chikage Kato, Akira Watanabe et autres

jp (code pays fourni par la source)

0 citations Research Square

2026 conference-abstract OpenAlex

Abstract PS1-05-27: A Multicenter Randomized Controlled Trial to Verify the Preventive Effect of Denosumab against Cancer Treatment-Induced Bone Loss (CTIBL) in Breast Cancer Patients Receiving Postoperative Endocrine Therapy with Normal Bone Density

Midori Morita, A. Watanabe, K. Sakaguchi, I. Takashi et autres

Abstract Background: Aromatase inhibitors (AIs) are widely used as postoperative endocrine therapy in patients with postmenopausal hormone receptor-positive breast cancer. The main side effect of AIs is bone loss, which is called cancer treatment-induced bone loss (CTIBL), and the use of bone …

jp (code pays fourni par la source)

0 citations Clinical Cancer Research

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.